RJM Group, LLC, is a consulting company that provides detailed health economics and outcomes information to the pharmaceutical industry to assist in establishing and defining product value. RJM accomplishes this by collecting and interpreting patient and practice-specific information and evidence obtained directly from healthcare providers.
RJM is currently conducting research in Germany, France, Italy, Spain, United Kingdom, Austria and Belgium and is presenting at international meetings. RJM has an extensive network of advisers who support and assist its work. These include physicians, private physician practices, academic medical centers, community hospitals, and outpatient clinics.
RJM is currently conducting research in Germany, France, Italy, Spain, United Kingdom, Austria and Belgium and is presenting at international meetings. RJM has an extensive network of advisers who support and assist its work. These include physicians, private physician practices, academic medical centers, community hospitals, and outpatient clinics.
Services
John is a graduate of the University of Nebraska, College of Pharmacy in Omaha, Nebraska where he earned his Bachelor of Science and Doctor of Pharmacy degrees.
Prior to becoming a founding partner of RJM Group, John's experience in healthcare includes positions as a Clinical Pharmacist at the University of Chicago Hospitals and Clinics in Chicago, Illinois, Clinical Pharmacy Coordinator and Assistant Director of Clinical Services at Cook County Hospital in Chicago, Illinois, and Director of Pharmacy and Central Supply at St. Anthony Medical Center, Crown Point, Indiana.
Prior to becoming a founding partner of RJM Group, John's experience in healthcare includes positions as a Clinical Pharmacist at the University of Chicago Hospitals and Clinics in Chicago, Illinois, Clinical Pharmacy Coordinator and Assistant Director of Clinical Services at Cook County Hospital in Chicago, Illinois, and Director of Pharmacy and Central Supply at St. Anthony Medical Center, Crown Point, Indiana.
Our work helping companies position their products in the marketplace is based on analytic data obtained from the relevant information source, and our recommendations are based on the evidence obtained in the process. Problem resolution involves problem identification, which is based on facts and evidence.
Clinical outcomes studies involve comparative effectiveness analysis to better understand the outcome achieved with the course of therapy studied. Time/motion studies identify the resources consumed (in time and money) both for the provider and the patient to help determine cost-effectiveness of care.
RJM coordinates and facilitates a panel of industry opinion leaders to help its clients understand buyer and provider specific perspectives that influence use of pharmaceutical drugs and medical devices. RJM will provide educational and resource development to support implementation and dissemination of the information obtained in the consulting engagement.
Stephane de Botton, Joseph M. Brandwein, Andrew H. We, et al. Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis. Mohty M, Azar N, Chabannon C, et al. Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.
Reviews
Be the first to review RJM Group.
Write a Review
